Andrei Pikalov, MD, PhD
- 14Articles
- 86.6KReads1
- 2007–2023Active
- 54Collaborators
- 579Citations2
About
Andrei Pikalov, MD, PhD, is affiliated with Sunovion Pharmaceuticals Inc. in Teaneck, New Jersey, and Marlborough, Massachusetts. Since 2007, Pikalov has published extensively on the treatment of psychiatric conditions including major depressive disorder, bipolar disorder, schizophrenia, and schizoaffective disorders. His work has focused on the clinical effects and safety of antipsychotic medications such as lurasidone and aripiprazole, addressing topics like anxiety symptoms, sexual dysfunction, metabolic syndrome, and movement disorders. Pikalov's research also encompasses neurology and sleep-related issues within these clinical populations.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
